Jazz Pharmaceuticals' (Nasdaq: JAZZ) 30.7% HIGHER; sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE